SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2018

Summary of the previously issued line items

	As Previously
	Reported		Adjustment		As Revised
Revised Consolidated Statements of Cash Flows
Three Months Ended March 31, 2017
Retirement and deferred compensation plan liabilities	$	(21,272)	$	(2,797)	$	(24,069)
Net Cash Provided by Operations		40,973		(2,797)		38,176
Proceeds from stock option exercises		15,908		2,797		18,705
Net Cash Provided (Used) by Financing Activities		(185,981)		2,797		(183,184)

Accounting Standards Update 2014-09 | Restatement of beginning balances

Summary of impacts of adoption of recent accounting pronouncements

		Balance at				Balance at
		December 31, 2017		Adjustment		January 1, 2018
Consolidated Balance Sheets
Assets
Inventories	$	337,216	$	(14,637)	$	322,579
Prepaid and other		109,791		13,984		123,775
Liabilities
Accounts payable and accrued liabilities		461,579		(5,706)		455,873
Deferred income taxes		20,995		1,292		22,287
Deferred and other non-current liabilities		5,608		824		6,432
Stockholders’ Equity
Retained earnings		1,301,147		2,937		1,304,084

Accounting Standards Update 2014-09 | Cumulative effect of change

Summary of impacts of adoption of recent accounting pronouncements

	For the Three Months Ended March 31, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Statements of Income
Net Sales
Beauty + Home	$	378,173	$	376,868	$	(1,305)
Pharma		230,127		230,462		335
Food + Beverage		95,050		95,100		50
Costs and Expenses
Cost of sales		455,822		454,900		(922)
Provision for income taxes		21,929		21,925		(4)
Net income		59,288		59,294		6

	March 31, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Balance Sheets
Assets
Accounts and notes receivable	$	586,592	$	600,576	$	13,984
Inventories		347,791		348,713		922
Prepaid and other		117,678		104,193		(13,485)
Liabilities
Accounts payable and accrued liabilities		496,409		497,815		1,406
Deferred income taxes		20,578		20,574		(4)
Deferred and other non-current liabilities		6,682		6,695		13
Stockholders’ Equity
Retained earnings		1,332,218		1,332,224		6

Accounting Standards Update 2017-07

Summary of impacts of adoption of recent accounting pronouncements

	Original				Revised
	Balance		Adjustment		Balance
Revised Condensed Consolidated Statements of Income
Three Months Ended March 31, 2017
Cost of sales	$	384,932	$	(248)	$	384,684
Selling, research & development and administrative		101,516		(234)		101,282
Total Operating Expenses		523,779		(482)		523,297
Operating Income		77,537		482		78,019
Miscellaneous, net		(77)		(482)		(559)
Total Other (Expense) Income		(8,057)		(482)		(8,539)
Income before Income Taxes		69,480		—		69,480